CompletedNCT04200248
A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration
PHASE2 · 94 planned enrolment
- Countries listed
- 1
- Registry update
- June 8, 2023
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
3 matching trial registrations
- Intervention RBM-007 Injectable Solution
Showing 1–3 of 3. Every record below meets all the filters shown above.
CompletedNCT04895293
RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration
PHASE1 · PHASE2 · 5 planned enrolment
- Countries listed
- 1
- Registry update
- April 12, 2023
CompletedNCT03633084
RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration
PHASE1 · PHASE2 · 9 planned enrolment
- Countries listed
- 1
- Registry update
- January 5, 2021